Indigo has acquired TellusLabs, a leader in the use of satellite technology and artificial intelligence whose mission is to build a living map of the world's food supply. TellusLabs' agricultural intelligence technology will integrate with Indigo's deep record of on-farm data, culminating in a platform that will provide growers and buyers with access to personalized, data-driven insights. The acquisition of TellusLabs will allow Indigo to further its commitment to improving g

Merger with OvaScience Closed Shares of Combined Company to Commence Trading on the Nasdaq Capital Market Under New Symbol “MLND” on Monday, December 10th, 2018 Proceeds of $85.4 Million to Fund Orphan Endocrine Pipeline Pivotal Phase 2b/3 Trial for Prader-Willi Syndrome Initiating in 1Q19 ANN ARBOR, Mich.--(BUSINESS WIRE)--Millendo Therapeutics, Inc. (Nasdaq: MLND), a clinical-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine disease